SPM-955

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSPM-955
Drug Alias NameVR1 antagonists (Schwarz Pharma/Pacific)vanilloid receptor antagonists (Schwarz Pharma/Pacific)PAC-20030MK-180SPM-14221 +[6] 
ClassificationSmall molecules
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPacific Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacific PharmaceuticalsUcb Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A